Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sidley Austin Beijing Senior Counsel Chen Yang: An Interview with PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Chen Yang, senior counsel in Sidley Austin's Beijing office, recently spoke with PharmAsia News about recent developments in China that affect the pharmaceutical and medical device industries. Yang leads the firm's China life sciences practice. For the past 10 years, she has advised international companies on their investment projects and acquisition efforts in various Chinese industries and provided regulatory advice on intellectual property, life science, employment and other issues. She has also assisted China government agencies in several U.S. litigation matters.

You may also be interested in...



Flagship Global Health And China Healthcare Ink Deal To Expand Insurance Services In China

 

Flagship Global Health And China Healthcare Ink Deal To Expand Insurance Services In China

 

China Biopharmaceutical Industry Will Grow To $17 Billion By 2015 – ResearchInChina Report

SHANGHAI - Production value of the Chinese pharmaceutical industry has grown at an annual average of 20 percent over the past decade, according to ResearchInChina's 2007-2008 China Biopharmaceutical Industry Report, issued in December. And China's biopharmaceutical industry is growing even faster than the traditional pharmaceutical industry, said the report

Related Content

UsernamePublicRestriction

Register

ID1132356

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel